Parkinson's UK
Overview
Parkinson's UK is a UK-based research and support charity that, through its drug development arm the Parkinson's Virtual Biotech, invests in projects and companies to accelerate new treatments for Parkinson's disease.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Mission Therapeutics | Jul 2024 | Grant | Co-investor |
| Keapstone Therapeutics | Sep 2018 | Seed | Lead |
| NRG Therapeutics | Sep 2025 | Series B | Co-investor |
| Endlyz Therapeutics | Mar 2026 | Seed | Co-investor |
| Lucy Therapeutics | May 2024 | VC Round | Co-investor |
For institutional investors. Book with your work email.
Key People
Jonathan Behr
Independent Director, Parkinson's Research Ventures Ltd.
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is Parkinson's UK based?
Parkinson's UK is headquartered in London, United Kingdom.
When was Parkinson's UK founded?
Parkinson's UK was founded in 1969.
How many portfolio companies does Parkinson's UK have?
Parkinson's UK has 7 portfolio companies in Caplight's dataset.
What are some companies in Parkinson's UK's portfolio?
Portfolio companies visible on Caplight include Mission Therapeutics, Keapstone Therapeutics, NRG Therapeutics, Endlyz Therapeutics, Lucy Therapeutics.
What was Parkinson's UK's most recent investment shown here?
Parkinson's UK's most recent investment in this portfolio sample was in Endlyz Therapeutics in 2026.
What sectors does Parkinson's UK focus on?
Parkinson's UK focuses on Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Consumer & Commerce, Healthcare & Life Sciences.
What company stages does Parkinson's UK focus on?
Parkinson's UK typically invests at the MultiStage stage.